You searched for "imaging"
Panos Dimitriadis: my experience of the CEORL-HNS
Many of us are invited to ENT conferences throughout the year and, as a trainee, it can sometimes be difficult to decide on which ones will be suitable for our stage in training. In this article, Amir Habeeb interviews Panos...The 7th Annual Hearing Technology Innovator Awards™
Hearing Health & Technology Matters is now accepting submissions for the 7th Annual Hearing Technology Innovator Awards™, an international awards programme recognising technological innovation and achievement across the hearing industry.The basis of the bargain: outcomes not inputs
There are international drivers focusing our attention on measuring outcomes; Anthony Hogan looks at the data to see how we are currently measuring up. Introduction A global paradigm change is impacting on the provision of disability services. At its heart,...Hearing rehabilitation after vestibular schwannoma surgery
Hearing rehabilitation is a key focus of the management of patients with vestibular schwannoma. But how do we rehabilitate hearing when the cochlear nerve has been damaged by tumour, irradiation, or resective surgery? Mathieu Trudel, Scott Rutherford and Simon Lloyd...Young CEORL-HNS: growing a pan-European ENT network
We are seeing a growth in the number of organisations supporting young ENT surgeons. Young CEORL-HNS is a thriving and expanding group. The Young Confederation of European ORL-HNS (Y-CEORL) was created with a simple idea in mind: to give young...
Immunosuppresants and ototoxicity
There is a wide range of immunosuppressant drugs ranging from calcineurin inhibitors (e.g. cyclosporine), anti-folic agents (e.g. methotrexate) to anti-TNF and monoclonal antibodies, many of which could be ototoxic. The authors performed a systematic review assessing ototoxicity secondary to immunosuppressant...
